Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-26

Clinical Trial Update: H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses [Phase 2]

View source ↗

Summary

Phase 2 trial results comparing H7N9 vaccination with AS03 adjuvant versus unadjuvanted H3N2v vaccination, including standard and systems biology analyses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AS03 adjuvant (AS03)
  • H3N2v vaccine
  • H7N9 vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Avian Influenza, H1N1 Influenza | Phase 2 | Status: COMPLETED | Results posted: 2022-01-26